Show Me the Data: Immunotherapy Across the Hepatobiliary Cancer Continuum—From Embolization-Eligible HCC to Advanced Biliary Tract Cancers

Join the conversation at PER's hybrid CME satellite symposium! This interactive format will feature emerging clinical evidence via real patient cases and decision points, covering treatment selection and multidisciplinary strategies across the HCC and BTC continuum.
 

• CE: 1.5 CME Hours
• Supported by: AstraZeneca
• Organized by: Physicians' Education Resource, LLC (PER)
• For more information and to register, visit: https://www.gotoper.com/courses/show-me-the-data-immunotherapy-across-the-hepatobiliary-cancer-continuumfrom-embolization-eligible-hcc-to-advanced-biliary-tract-cancers?utm_medium=website&utm_source=thirdparty&utm_campaign=assoc_website